The Iodixanol Injection, cataloged under National Stock Number 6505-01-552-4221, is classified within Federal Supply Class 6505 (No Item Name Available) of the Medical, Dental, and Veterinary Equipment group. The primary manufacturer of record is Ge Healthcare Inc Dba Ge Healthcare. Government technical data includes 1 verified specification, sourced from the Federal Logistics Information System (FLIS). This item has 4 commercial cross-references from 3 manufacturers, enabling identification through both NSN and commercial part number lookups. 7 verified substitutes exist in the FLIS interchangeability database. Current acquisition status: Active. Unit of issue: PG.
| Parameter | Value |
|---|---|
| NSN | 6505-01-552-4221 |
| Primary Part Number | NDC00407-2222-54 |
| Item Name | Iodixanol Injection |
| FSC / FSG | 6505 / 65 — No Item Name Available |
| Manufacturer | Ge Healthcare Inc Dba Ge Healthcare |
| Status | ACTIVE |
| Protective Storage Feature | CONTROLLED ROOM TEMPERATURE |
| Acquisition Status | ACTIVE |
| HAZMAT | No |
| Unit of Issue | PG |
| Part Number | Manufacturer |
|---|---|
| 3786 | Defense Logistics Agency Directorate of Medical Materiel Defense Supply Center Philadelphia (USA) |
| VISIPAQUE 270MG/ML 10 X 150ML | Ge Healthcare Inc Dba Ge Healthcare (USA) |
| 6505NCM071437 | Defense Medical Standardization Board (USA) |
| NDC00407-2222-54 PRIMARY | Ge Healthcare Inc Dba Ge Healthcare (USA) |
NSN 6505-01-552-4221 is a Iodixanol Injection, manufactured by Ge Healthcare Inc Dba Ge Healthcare, classified under FSC 6505 (No Item Name Available). Status: active.
NSN 6505-01-552-4221 has 4 cross-referenced part numbers: 3786 (Defense Logistics Agency Directorate of Medical Materiel Defense Supply Center Philadelphia), VISIPAQUE 270MG/ML 10 X 150ML (Ge Healthcare Inc Dba Ge Healthcare), 6505NCM071437 (Defense Medical Standardization Board), NDC00407-2222-54 (Ge Healthcare Inc Dba Ge Healthcare).
There are 7 known substitutes for 6505-01-552-4221: 6505-00-062-4834, 5815-00-065-4862, 5985-00-295-3917 and 4 more. Verify interchangeability with system specifications before substitution.
Key specifications for NDC00407-2222-54: Part Name Assigned by Controlling Agency: IODIXANOL INJ VISIPAQUE 270MG/150ML10S; Special Features: 270MG IODIXANOL PER 150ML; FOR INTRAVASCULAR USE; INDECATED FOR INTRA-ARTERIAL DIGITAL SUBRACTION ANGIOGRAPHY; INDICATED FOR CONTRAST ENHANCED COMPUTER TOOGRAPHY (CECT) IMAGING OF THE HEAD AND BODY, EXCRETORY UROGRAPHY AND ERIPHERAL VENOGRAPHY; STORE AT CONTROLLED ROOM TEMPERATURE, 20 C-25 C (68 F-77 F);EXCURSIONS PERMITTED TO 15 C-30 C (59 F-86 F) (SEE USP CONTROLLED ROOM TEMPERATURE); Protective Storage Feature: CONTROLLED ROOM TEMPERATURE. 3 total characteristics are documented in the Federal Logistics Information System.